The product is used to delay the progression of children’s myopia aged 6-12 with spherical lenses of -1.00D to -4.00D (astigmatism≤1.50D and anisometropia≤1.50D)
Promotes tear secretion in patients with dry eyes. For patients with reduced tear secretion caused by ocular inflammation associated with keratoconjunctivitis sicca.
For keratohelcosis and corneal injury due to various causes, corneal bum caused by acid or alkali, bullous keratitis, neuroparalytic keratitis, as well as corneal and conjunctival degeneration.
For keratohelcosis and corneal injury due to various causes, corneal bum caused by acid or alkali, bullous keratitis, neuroparalytic keratitis, as well as corneal and conjunctival degeneration.
Xingqi was named to the “Top Employer China 2023” by 51jobs in January 2023. Xingqi was awarded t... 【Details】
2023-08-16
Gao E, director and deputy general manager of Xingqi, was elected as a member of CPPCC Shenyang i... 【Details】
2022-08-25
Liaoning Inspection, Examination and Certification Center presents Sinqi Ophthalmic Medications t... 【Details】
2021-07-29
Liaoning Provincial Development and Reform Commission appropriated funds of the central budget ... 【Details】
2020-12-05
After the former high-tech enterprise certificate expired, the company was recognized as a high... 【Details】
2020-12-05
April 28, 2018: xingqi ophthalmic employees were awarded "district model worker" and "May 4th med... 【Details】
2019-01-16